U S PHYSICAL THERAPY INC /NVUSPHEarnings & Financial Report
NYSE
USPH Q3 2025 Key Financial Metrics
Revenue
$197.1M
Gross Profit
$36.9M
Operating Profit
$25.3M
Net Profit
$13.1M
Gross Margin
18.7%
Operating Margin
12.8%
Net Margin
6.7%
YoY Growth
17.3%
EPS
$0.48
Financial Flow
U S PHYSICAL THERAPY INC /NV Q3 2025 Financial Summary
U S PHYSICAL THERAPY INC /NV reported revenue of $197.1M for Q3 2025, with a net profit of $13.1M (6.7% margin). Cost of goods sold was $160.3M, operating expenses totaled $11.5M.
Key Financial Metrics
| Total Revenue | $197.1M |
|---|---|
| Net Profit | $13.1M |
| Gross Margin | 18.7% |
| Operating Margin | 12.8% |
| Report Period | Q3 2025 |
U S PHYSICAL THERAPY INC /NV Annual Revenue by Year
U S PHYSICAL THERAPY INC /NV annual revenue history includes year-by-year totals (for example, 2024 revenue was $671.3M).
| Year | Annual Revenue |
|---|---|
| 2024 | $671.3M |
| 2023 | $604.8M |
| 2022 | $553.1M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $154.8M | $155.7M | $167.2M | $168.0M | $180.4M | $183.8M | $197.3M | $197.1M |
| YoY Growth | 9.6% | 4.8% | 10.4% | 12.0% | 16.6% | 18.1% | 18.0% | 17.3% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $997.2M | $1.02B | $1.02B | $1.03B | $1.17B | $1.18B | $1.18B | $1.20B |
| Liabilities | $345.0M | $345.3M | $353.2M | $358.5M | $408.4M | $420.7M | $414.0M | $413.8M |
| Equity | $476.2M | $479.8M | $484.6M | $482.8M | $488.9M | $497.3M | $500.8M | $503.6M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $26.8M | $4.4M | $29.0M | $22.1M | $19.4M | $-4.7M | $34.9M | $19.9M |